Pamela Munster will join the Stanford Cancer Institute as the inaugural associate director for early detection and interception research on Aug. 1.
NRG Oncology announced changes in leadership across multiple committees.
Pamela Munster named inaugural associate director for early detection and interception research at Stanford
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Michelle Ozbun was appointed associate director for basic research of the University of New Mexico Comprehensive Cancer Center.
Alastair Thompson was named director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s Vera Bradley Foundation Center for Breast Cancer Research.
Kate Markey, an assistant professor at Fred Hutch Cancer Center and UW Medicine, has recently been named the next holder of the Innovators Network Endowed Chair.
The members of the American Society for Radiation Oncology recently elected five officers to ASTRO’s board of directors.
Curebound has announced three new key leaders: Mary Meyer as chief advancement officer, Scotty Cadet as chief scientific officer and vice president of research, and Leena Gupta as chief financial officer.
